Diakonos Oncology Names Paul Lammers, M.D., Veteran BioPharma Senior Executive, to its Board of Directors
HOUSTON–(February 20, 2024)–Diakonos Oncology Corp. (“Diakonos”), a clinical stage immuno-oncology company, announced today that Paul Lammers, M.D., M.Sc., a distinguished executive with over 35 years of experience in the biotech and pharmaceutical industries, has been named to its Board of Directors. “Dr. Lammers’ success in leading both private and public biopharma companies, combined with his […]
Read More